HIV-infected individuals experience accelerated vascular aging and an increased risk of vascular disorders. Vascular dysfunction, similar to that underlying vascular dementia and depression seen in aging HIV-negative populations, may contribute to the continued high rates of HIV-associated neurocognitive disorders seen in the effective antiretroviral therapy era. One diagnostic marker of vasculopathy is thickening of the vessel wall. Studies have established a correlation between vessel wall thickening and vascular disease manifestations. This prospective, observational study aimed to examine the relationships between neurocognitive outcomes and vessel wall thickness as a marker of vascular disease in HIV-infected adults. Study procedures included neuropsychological testing, brain imaging, blood biomarkers, magnetic resonance imaging of the carotid vessel walls and computed tomography of the heart. HIV-infected patients (n=40) and age-, sex-, and race-matched HIV-negative controls (n=40) will be recruited. Participants will be followed for two years, with clinical evaluations every 6 months and repeat imaging studies at 12 and 24 months. Cross-sectional analysis will compare markers of vascular and neurocognitive disorders between HIV-infected and HIV-negative participants. The longitudinal data analysis will assess and compare the temporal progression of vascular disease (imaging and blood biomarker findings) in relation to changes in neurocognitive and depression scores in both groups. 84 participants enrolled, 56 HIV-infected adults and 28 HIV-negative controls. In the study analysis, carotid vessel wall thickness was increased in those with HIV compared to controls. Additionally, atherosclerotic cardiovascular disease risk was closely related to vessel wall thickness independent of HIV infection. The study was closed in April 2018 after the original PI left the NIH and the study analysis was completed.

Agency
National Institute of Health (NIH)
Institute
Clinical Center (CLC)
Type
Investigator-Initiated Intramural Research Projects (ZIA)
Project #
1ZIACL090029-07
Application #
9785984
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
7
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Clinical Center
Department
Type
DUNS #
City
State
Country
Zip Code
Mee, Thomas C; Aepfelbacher, Julia; Krakora, Rebecca et al. (2018) Carotid magnetic resonance imaging in persons living with HIV and 10-year atherosclerotic cardiovascular disease risk score. Antivir Ther :
Siyahhan Julnes, Peter; Auh, Sungyoung; Krakora, Rebecca et al. (2016) The Association Between Post-traumatic Stress Disorder and Markers of Inflammation and Immune Activation in HIV-Infected Individuals With Controlled Viremia. Psychosomatics 57:423-30
Ances, Beau M; Hammoud, Dima A (2014) Neuroimaging of HIV-associated neurocognitive disorders (HAND). Curr Opin HIV AIDS 9:545-51
Ko, Christine; Kaushal, Aradhana; Hammoud, Dima A et al. (2012) Role of early postradiation magnetic resonance imaging scans in children with diffuse intrinsic pontine glioma. Int J Radiat Oncol Biol Phys 83:1252-1256
Ratchford, John N; Endres, Christopher J; Hammoud, Dima A et al. (2012) Decreased microglial activation in MS patients treated with glatiramer acetate. J Neurol 259:1199-205
Endres, Christopher J; Hammoud, Dima A; Pomper, Martin G (2011) Reference tissue modeling with parameter coupling: application to a study of SERT binding in HIV. Phys Med Biol 56:2499-513
Kreisl, Teri N; Zhang, Weiting; Odia, Yazmin et al. (2011) A phase II trial of single-agent bevacizumab in patients with recurrent anaplastic glioma. Neuro Oncol 13:1143-50
Hipp, Sean J; Steffen-Smith, Emilie; Hammoud, Dima et al. (2011) Predicting outcome of children with diffuse intrinsic pontine gliomas using multiparametric imaging. Neuro Oncol 13:904-9